Robert Steffen

Last updated
Robert Steffen
Alma mater
Awards
  • Honorary Fellow of the Australasian College of Tropical Medicine [1]
Scientific career
Institutions University of Zurich

Robert Steffen is an Emeritus Professor at the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland [2] and an adjunct professor at the University of Texas School of Public in Houston. He is an editor of the Journal of Travel Medicine. [3] [4]

Contents

Education

Robert Steffen was born and raised in Zurich. He was a medical student at the local university and towards the end of his medical studies, he was elected as the president of the International Federation of Medical Students Association. [5] [6]

He initially trained to become a flight surgeon at the Swiss Air Force Medical Institute. Subsequently, he obtained a broad education in Internal medicine and epidemiology at academic institutions in Sydney, Nairobi, Johannesburg, Chicago, San Francisco, and London.

Research and career

Steffen's research focused on the epidemiology and prevention of infectious diseases in travelers. Areas of research included malaria, vaccines and travelers’ diarrhea. [7] [8] [9] He conducted a study on the oral antibiotic formulation Rifamycin SV – MMX for treating traveler’s diarrhea and also promoted researches on the interests of older travelers. [10] [11] Lately he focused on a viral infection called Tick-borne encephalitis (TBE). [12] [13] [14]

In the early days of his career, he served as a Chief Border Physician at the Zurich Airport. [15] Steffen served as Chair of the 2018 IHR Emergency Committee and Vice-Chair of the 2014-2016 IHR Emergency Committee for Ebola Virus Disease (EVD). [16] [17] [18] [19] [20] [21] [22] During the Gulf War he was the leader of Task Force Scorpio. [23]

Awards and honors

He currently serves as the member of the Swiss Society for Infectious Diseases and an honorary fellow of the Australasian College of Tropical Medicine. [24] [25] Additional award includes the Bronze Medal of the City of Paris and also received the honor of serving as the chairman of the W.H.O. emergency committee. [26] He also has served as the President for International Society of Travel Medicine (ISTM). [27]

Publications

Related Research Articles

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

<span class="mw-page-title-main">Arbovirus</span> Class of viruses which are transmitted by arthropods

Arbovirus is an informal name for any virus that is transmitted by arthropod vectors. The term arbovirus is a portmanteau word. Tibovirus is sometimes used to more specifically describe viruses transmitted by ticks, a superorder within the arthropods. Arboviruses can affect both animals and plants. In humans, symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last three or four days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and viral hemorrhagic fever may also occur.

<span class="mw-page-title-main">Travelers' diarrhea</span> Stomach and intestinal infection

Travelers' diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool while traveling. It may be accompanied by abdominal cramps, nausea, fever, headache and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within three to four days with little or no treatment. About 12% of people may have symptoms for a week.

<span class="mw-page-title-main">Travel medicine</span> Branch of medicine

Travel medicine or emporiatrics is the branch of medicine that deals with the prevention and management of health problems of international travelers.

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. They are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. The economic impact of tick-borne diseases is considered to be substantial in humans, and tick-borne diseases are estimated to affect ~80 % of cattle worldwide. Most of these pathogens require passage through vertebrate hosts as part of their life cycle. Tick-borne infections in humans, farm animals, and companion animals are primarily associated with wildlife animal reservoirs. Many tick-borne infections in humans involve a complex cycle between wildlife animal reservoirs and tick vectors. The survival and transmission of these tick-borne viruses are closely linked to their interactions with tick vectors and host cells. These viruses are classified into different families, including Asfarviridae, Reoviridae, Rhabdoviridae, Orthomyxoviridae, Bunyaviridae, and Flaviviridae.

<span class="mw-page-title-main">Tick-borne encephalitis</span> Medical condition

Tick-borne encephalitis (TBE) is a viral infectious disease involving the central nervous system. The disease most often manifests as meningitis, encephalitis or meningoencephalitis. Myelitis and spinal paralysis also occurs. In about one third of cases sequelae, predominantly cognitive dysfunction, persist for a year or more.

<i>Tick-borne encephalitis virus</i> Species of virus

Tick-borne encephalitis virus (TBEV) is a positive-strand RNA virus associated with tick-borne encephalitis in the genus Flavivirus.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

Alkhurma virus (ALKV) is a zoonotic virus of the Flaviviridae virus family. ALKV causes Alkhurma hemorrhagic fever (AHF), or alternatively termed as Alkhurma hemorrhagic fever virus, and is mainly based in Saudi Arabia.

<span class="mw-page-title-main">Ehrlichiosis</span> Medical condition

Ehrlichiosis is a tick-borne bacterial infection, caused by bacteria of the family Anaplasmataceae, genera Ehrlichia and Anaplasma. These obligate intracellular bacteria infect and kill white blood cells.

Aircraft disinsection is the use of insecticide on international flights and in other closed spaces for insect and disease control. Confusion with disinfection, the elimination of microbes on surfaces, is not uncommon. Insect vectors of disease, mostly mosquitoes, have been introduced into and become indigenous in geographic areas where they were not previously present. Dengue, chikungunya and Zika spread across the Pacific and into the Americas by means of the airline networks. Cases of "airport malaria", in which live malaria-carrying mosquitoes disembark and infect people near the airport, may increase with global warming.

<span class="mw-page-title-main">Tick-borne encephalitis vaccine</span> Vaccine against tick-borne encephalitis

Tick-borne encephalitis vaccine is a vaccine used to prevent tick-borne encephalitis (TBE). The disease is most common in Central and Eastern Europe, and Northern Asia. More than 87% of people who receive the vaccine develop immunity. It is not useful following the bite of an infected tick. It is given by injection into a muscle.

Ticks are insects known for attaching to and sucking blood from land-dwelling animals. Ticks fall under the category of 'arthropod', and while they are often thought of in the context of disease transmission, they are also known to cause direct harm to hosts through bites, toxin release, and infestation. Infestation can cause symptoms ranging from mild to severe and may even cause death. Hosts can include any number of vertebrates, though humans and livestock are more likely to be the interest of researchers.

<span class="mw-page-title-main">African tick bite fever</span> Medical condition

African tick bite fever (ATBF) is a bacterial infection spread by the bite of a tick. Symptoms may include fever, headache, muscle pain, and a rash. At the site of the bite there is typically a red skin sore with a dark center. The onset of symptoms usually occurs 4–10 days after the bite. Complications are rare but may include joint inflammation. Some people do not develop symptoms.

<span class="mw-page-title-main">Public health emergency of international concern</span> Formal declaration by the World Health Organization

A public health emergency of international concern is a formal declaration by the World Health Organization (WHO) of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response", formulated when a situation arises that is "serious, sudden, unusual, or unexpected", which "carries implications for public health beyond the affected state's national border" and "may require immediate international action". Under the 2005 International Health Regulations (IHR), states have a legal duty to respond promptly to a PHEIC. The declaration is publicized by an IHR Emergency Committee (EC) of international experts, which was developed following the 2002–2004 SARS outbreak.

<span class="mw-page-title-main">Bavarian Nordic</span> Pharmaceutical company

Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development.

A monkey bite is the bite of a monkey and is the second most common animal bite after dog bites in India. Monkey bites account for 2–21% of animal bite injuries. Monkey bites are an important risk among travelers and after dog bites is the most common animal bite for travelers. Treatment depends upon many factors including the suspicion of rabies. Management involves:

Travel health nursing is a nursing specialty which promotes the health and safety of national and international travelers. Similar to travel medicine, it is an interdisciplinary practice which draws from the knowledge bases of vaccines, epidemiology, tropical medicine, public health, and health education. Travel nursing has experienced an increase in global demand due to the evolution of travel medicine. Travel health nursing was recognized during the 1980s as an emerging occupation to meet the needs of the traveling public, and additional education and training was established. Travel health nurses typically work in "private practice, hospital outpatient units, universities, the government, and the military", and have more opportunities and leadership roles as travel has become more common. However, they also experience organizational and support-related conflicts with general practitioners and patients in healthcare settings.

<span class="mw-page-title-main">Climate change and infectious diseases</span> Overview of the relationship between climate change and infectious diseases

Global climate change has increased the occurrence of some infectious diseases. Infectious diseases whose transmission is impacted by climate change include, for example, vector-borne diseases like dengue fever, malaria, tick-borne diseases, leishmaniasis, zika fever, chikungunya and Ebola. One mechanism contributing to increased disease transmission is that climate change is altering the geographic range and seasonality of the insects that can carry the diseases. Scientists stated a clear observation in 2022: "The occurrence of climate-related food-borne and waterborne diseases has increased ."

Christian Kunz was an Austrian virologist known for his work on the development of vaccines against tick-borne encephalitis, and his contributions to viral diagnostics and medical virology in Austria and Europe.

References

  1. "Robert Steffen". who.int.
  2. "WHO | Biographies of the members of, and advisers to, the IHR Emergency Committee regarding the Ebola outbreak in West Africa". WHO. Retrieved 2020-02-13.
  3. "WHO | Biographies of Members of, and Advisers to the Meeting of the International Health Regulations (IHR) Emergency Committee for Ebola Viral Disease in the Democratic Republic of the Congo on 12 April 2019". WHO. Archived from the original on April 17, 2019. Retrieved 2020-02-13.
  4. "Editorial_Board". Oxford Academic. Retrieved 2020-02-13.
  5. "Past Officials". International Federation of Medical Students' Associations (IFMSA). Retrieved 2019-08-13.
  6. "Honorary Life Members". International Federation of Medical Students' Associations (IFMSA). Retrieved 2019-08-13.
  7. Steffen, Robert; Lobel, Hans O. (1994-02-01). "Epidemiologic basis for the practice of travel medicine". Journal of Wilderness Medicine. 5 (1): 56–66. doi:10.1580/0953-9859-5.1.56. ISSN   0953-9859.
  8. Steffen, Robert (2017-04-01). "Epidemiology of travellers' diarrhea". Journal of Travel Medicine. 24 (suppl_1): S2–S5. doi: 10.1093/jtm/taw072 . ISSN   1195-1982. PMID   28520996.
  9. Steffen. "Travel health - Travel medicine". www.thejhs.org. Retrieved 2020-02-17.
  10. Steffen, Robert; Jiang, Zhi-Dong; Gracias Garcia, Mónica L.; Araujo, Prithi; Stiess, Michael; Nacak, Tanju; Greinwald, Roland; DuPont, Herbert L. (2018-01-01). "Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria". Journal of Travel Medicine. 25 (1). doi:10.1093/jtm/tay116. ISSN   1195-1982. PMC   6331114 . PMID   30462260.
  11. Flaherty, Gerard T.; Rossanese, Andrea; Steffen, Robert; Torresi, Joseph (2018-01-01). "A golden age of travel: advancing the interests of older travellers". Journal of Travel Medicine. 25 (1). doi: 10.1093/jtm/tay088 . ISSN   1195-1982. PMID   30239856.
  12. Steffen, Robert (2019). "Tick-borne encephalitis (TBE) in children in Europe: Epidemiology, clinical outcome and comparison of vaccination recommendations". Ticks and Tick-Borne Diseases. 10 (1): 100–110. doi: 10.1016/j.ttbdis.2018.08.003 . ISSN   1877-9603. PMID   30241699.
  13. Steffen, Robert; Bouchama, Abderrezak; Johansson, Anders; Dvorak, Jiri; Isla, Nicolas; Smallwood, Catherine; Memish, Ziad A (2012-02-01). "Non-communicable health risks during mass gatherings". The Lancet Infectious Diseases. 12 (2): 142–149. doi:10.1016/S1473-3099(11)70293-6. ISSN   1473-3099. PMID   22252147.
  14. Steffen, Robert (2016-07-01). "Epidemiology of tick-borne encephalitis (TBE) in international travellers to Western/Central Europe and conclusions on vaccination recommendations". Journal of Travel Medicine. 23 (4). doi: 10.1093/jtm/taw018 . ISSN   1195-1982. PMID   27087558.
  15. "Im Kampf gegen Sars, Malaria und Diarrhö | NZZ". Neue Zürcher Zeitung (in German). Retrieved 2020-02-13.
  16. "Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern". PAHO.org. 17 July 2019.
  17. "No emergency declaration for Ebola, WHO says". Devex. 2018-10-17. Retrieved 2020-02-13.
  18. Gallagher, James (2019-04-12). "Ebola outbreak 'not global emergency yet'". BBC News. Retrieved 2020-02-13.
  19. Ebola outbreak declared global health emergency - VIDEO , retrieved 2019-08-13
  20. "WHO declares Ebola in Congo to be emergency of 'international concern'". The Washington Post .
  21. "WHO sounds Ebola alarm as risks intensify". www.msn.com. Retrieved 2019-08-13.
  22. "DRC's Ebola outbreak an 'emergency' - Chinadaily.com.cn". www.chinadaily.com.cn. Retrieved 2019-08-13.
  23. Woodall, John Jack (2016-02-08). "WHO reform: bring back GOARN and Task Force 'Scorpio'". Infection Ecology & Epidemiology. 6: 30237. doi:10.3402/iee.v6.30237. ISSN   2000-8686. PMC   4748086 . PMID   26860977.
  24. "Members – Swiss Society for Infectious Diseases". www.sginf.ch. Retrieved 2020-02-13.
  25. "WHO | Biographies of the members of, and advisers to, the IHR Emergency Committee regarding the Ebola outbreak in West Africa". WHO. Retrieved 2020-02-13.
  26. Grady, Denise (2019-07-17). "Ebola Outbreak in Congo Is Declared a Global Health Emergency". The New York Times. ISSN   0362-4331 . Retrieved 2020-02-13.
  27. "The International Society of Travel Medicine". www.istm.org. Retrieved 2019-08-13.
  28. Steffen, Robert (2016). "Epidemiology of tick-borne encephalitis (TBE) in international travellers to Western/Central Europe and conclusions on vaccination recommendations". Journal of Travel Medicine. 23 (4). doi: 10.1093/jtm/taw018 . ISSN   1708-8305. PMID   27087558.
  29. Steffen, Robert; Jiang, Zhi-Dong; Gracias Garcia, Mónica L.; Araujo, Prithi; Stiess, Michael; Nacak, Tanju; Greinwald, Roland; DuPont, Herbert L. (2018). "Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria". Journal of Travel Medicine. 25 (1). doi:10.1093/jtm/tay116. ISSN   1708-8305. PMC   6331114 . PMID   30462260.
  30. Steffen, Robert; Hill, David R.; DuPont, Herbert L. (2015-01-06). "Traveler's diarrhea: a clinical review". JAMA. 313 (1): 71–80. doi:10.1001/jama.2014.17006. ISSN   1538-3598. PMID   25562268.
  31. Steffen, Robert (2018). "Travel vaccine preventable diseases-updated logarithmic scale with monthly incidence rates". Journal of Travel Medicine. 25 (1). doi: 10.1093/jtm/tay046 . ISSN   1708-8305. PMID   30016468.
  32. Steffen, Robert (2010). "Influenza in travelers: epidemiology, risk, prevention, and control issues" (PDF). Current Infectious Disease Reports. 12 (3): 181–185. doi:10.1007/s11908-010-0100-9. ISSN   1534-3146. PMC   7088976 . PMID   21308527.